Modeling the potential public health and economic impact and cost-effectiveness of vaccination strategies using a COVID-19 vaccine in Costa Rica
Implementing an adapted COVID-19 vaccine strategy for high-risk and older adults in Costa Rica is expected to be cost-saving, with broader age group eligibility yielding even greater benefits.
Authors
- Elena Aruffo (ORCID: https://orcid.org/0000-0002-8546-3498)
- Carlos Fernando Mendoza
- Marcel Marcano-Lozada
- Juan José Baldi-Castro
- Iustina Chirila
- Ben Yarnoff
- Karen Villamil-Herrera
- Moe H Kyaw
- Leo Alejandro Barrantes
Institutions
- Ithaka Harbors (US)
- Pfizer (United States) (US)
- Universidad de Costa Rica (CR)
Publication Details
- Journal
- Expert Review of Vaccines
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1080/14760584.2026.2634800
- Primary Topic
- Vaccine Coverage and Hesitancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00